Tricida to Host Investor Day on October 15, 2019
Management to unveil veverimer (TRC101) U.S. commercialization strategy following recent NDA submission Leading clinicians and researchers to discuss implications of…
Pharmaceuticals, Biotechnology and Life Sciences
Management to unveil veverimer (TRC101) U.S. commercialization strategy following recent NDA submission Leading clinicians and researchers to discuss implications of…
DUBLIN–(BUSINESS WIRE)–The “Western Blotting Market to 2027 – Global Analysis and Forecasts By Product; Application; End User, and Geography” report…
HOBOKEN, N.J.–(BUSINESS WIRE)–#FVIII—Octapharma USA is sponsoring the National Hemophilia Foundation’s (NHF) 71st Bleeding Disorders Conference and introducing two new clinical…
– Results from DISCOVER Trial Provide Bone and Renal Safety Profile Data from Participants who Switched from Truvada for PrEP®…
VALLEY FORGE, Pa.–(BUSINESS WIRE)–AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter…
VALLEY FORGE, Pa.–(BUSINESS WIRE)–AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter…
ALACHUA, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH) announced today that it has completed its name change from CTD Holdings, Inc.…
ALACHUA, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH) announced today that it has completed its name change from CTD Holdings, Inc.…
Publication highlights pre-clinical and clinical activity of poziotinib in lung cancer patients with HER2 mutations and potential future applications using…
Publication highlights pre-clinical and clinical activity of poziotinib in lung cancer patients with HER2 mutations and potential future applications using…